🟢 Eupraxia Pharmaceuticals is trading 12.6% up in after-hours trading — move remains unexplained

Eupraxia Pharmaceuticals is trading at $7.50 (+12.61%) in after-hours trading; the move remains unexplained.

• No confirmed August 6, 2026 company-specific announcement, earnings release, or late-breaking catalyst was identified.
• Recent coverage focused on leadership changes and clinical-trial developments, including July 2026 board appointments and an operating overhaul—not new information released August 6.
• Broader biotechnology sentiment was modestly positive: the IBB ETF rose 0.3%, but this does not establish causation. Limited after-hours liquidity or a delayed reaction to earlier developments may also be factors.